B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained an Underperform rating on Core Laboratories (NYSE:CLB) and lowered the price target from $16 to $15.
July 15, 2024 | 4:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities has maintained an Underperform rating on Core Laboratories and lowered the price target from $16 to $15.
The Underperform rating and lowered price target from a major analyst firm like B of A Securities is likely to negatively impact investor sentiment and short-term stock price for Core Laboratories.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100